Posts

Revolutionizing Agriculture: Advanced AI Techniques Enh...

A revolutionary leap in agricultural technology has been unveiled by a collabora...

Groundbreaking Study Reveals the Origins of Africa’s La...

In recent years, research into the genetic diversity of the Fulani, one of Afric...

Biosensing Platform Enables Concurrent Detection of Vit...

In a groundbreaking development in the field of biosensing technologies, researc...

Revolutionary Smart Sensor Streamlines Wound Monitoring

In a groundbreaking development, researchers from Penn State University and Chin...

Dana-Farber Researchers Unveil Breakthrough Findings at...

Boston – As the realm of cancer treatment continues to evolve, the upcoming 2025...

Non-Coding RNA: Key Players in Protein Synthesis and Ce...

In a groundbreaking study, researchers at The Ohio State University have made si...

Sexual Desire: The Powerful Force That Both Unites and ...

A new research article authored by Prof. Gurit Birnbaum, a prominent researcher ...

Insilico Medicine Unveils Key Developmental Milestones ...

In an era where biotechnology is rapidly evolving through the integration of art...

Keymed’s Stapokibart approved by NMPA for seasonal alle...

China's NMPA has granted approval for Keymed Biosciences’ supplemental NDA of St...

Fourth person receives eGenesis’ gene-edited pig kidney...

Tim Andrews underwent the procedure with the pig kidney as part of a three-perso...

Super Bowl ad for copycat weight loss drugs stokes phar...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in ...

Eton secures US patent for diabetes insipidus treatment

Eton has secured a patent from the USPTO for its ET-600 product candidate’s desm...

FDA approves AbbVie’s Emblaveo for intra-abdominal infe...

AbbVie has received US FDA approval for Emblaveo to be used in conjunction with ...

Obesity market to reach $173.5 billion by 2031

Given the number of comorbidities associated with obesity, the market's growth w...

Bio-Thera signs US deal with Intas for golimumab biosim...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreem...

Boehringer seeks approval of lung disease drug after se...

Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster...